Analyse du microbiome en vente directe au consommateur : principales conclusions et analyse des parts de marché d'ici 2025-2031
Direct to Consumer Microbiome Analyzing Market Report Analysis
Direct to Consumer Microbiome Analyzing Market
-
CAGR (2023 - 2031)XX% -
Market Size 2023
US$ XX million -
Market Size 2031
US$ XX Million
Report Coverage
- Market size and forecast at global, regional, and country levels for all the key market segments covered under the scope
- Key future trends
- Detailed PEST/Porter’s Five Forces and SWOT analysis
- Industry landscape and competition analysis & recent developments
- Detailed company profiles
- Global and regional market analysis covering key market trends, major players, regulations, and recent market developments
Key Players
- Atlas Biomed Group Limited.
- Viome, Inc.
- 23andMe, Inc
- uBiome
- Carbiotix AB
- BIOMES NGS GmbH
- Quantbiome, Inc.
- TFTAK
Regional Overview
- Amérique du Nord
- Europe
- Asie-Pacifique
- Amérique du Sud et centrale
- Moyen-Orient et Afrique
Market Segmentation
By Produit
- kits de test du microbiome intestinal
- kits d'échantillons de santé
- autres kits de test du microbiome
By Application
- infections
- affections intestinales
- troubles métaboliques
- maladies cardiovasculaires
- autres
By Utilisateur final
- hôpitaux
- cliniques
- centres de diagnostic
- autres
By Géographie
- Amérique du Nord
- Europe
- Asie-Pacifique
- Amérique du Sud et Centrale
Get Free Sample For